Case series: 7 cases of myocarditis following mRNA-based COVID-19 vaccination.
Myocarditis after BNT162b2 and mRNA-1273 Vaccination – Circulation Commentary: Study details the treatment of COVID-19 vaccine-associated myocarditis-like illness in 7 patients – News Medical Related: CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare. AND Israel reports link between rare cases of heart […]
The post Case series: 7 cases of myocarditis following mRNA-based COVID-19 vaccination. appeared first on Links Medicus.
CDC now calls coronavirus Delta variant a ‘variant of concern’.
CDC now calls coronavirus Delta variant a ‘variant of concern’ – CNN Guidance: SARS-CoV-2 Variant Classifications and Definitions – Centers for Disease Control and Prevention Commentary on Twitter BREAKING—CDC now officially declares #DeltaVariant a “variant of concern”—because much more transmissible (50% faster than #B117, 2x than original strain), more severe (2.5x hospitalization risk than […]
The post CDC now calls coronavirus Delta variant a ‘variant of concern’. appeared first on Links Medicus.
[Preprint] RECOVERY trial finds Regeneron’s monoclonal antibody combination reduces deaths for hospitalized COVID-19 patients who have not mounted their own immune response.
News release: RECOVERY trial finds Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response Original study (preprint): Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv Commentaries: Monoclonal antibodies cut risk of dying from COVID-19—but only […]
The post [Preprint] RECOVERY trial finds Regeneron’s monoclonal antibody combination reduces deaths for hospitalized COVID-19 patients who have not mounted their own immune response. appeared first on Links Medicus.
RCT: Tofacitinib reduced the risk of death or respiratory failure in patients hospitalized with Covid-19 pneumonia.
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia – New England Journal of Medicine News release: Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia Commentary on Twitter: Patients who were hospitalized with #COVID19 pneumonia were randomly assigned, at a median […]
The post RCT: Tofacitinib reduced the risk of death or respiratory failure in patients hospitalized with Covid-19 pneumonia. appeared first on Links Medicus.
RCT: A brief advice + nicotine replacement therapy sampling + active referral nearly doubled the odds of validated quitting among expectant fathers who smoked.
Brief Advice, Nicotine Replacement Therapy Sampling, and Active Referral for Expectant Fathers Who Smoke Cigarettes: A Randomized Clinical Trial – JAMA Internal Medicine (free for a limited period)
The post RCT: A brief advice + nicotine replacement therapy sampling + active referral nearly doubled the odds of validated quitting among expectant fathers who smoked. appeared first on Links Medicus.
M-A: Extracorporeal membrane oxygenation for COVID-19.
Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis – Critical Care
The post M-A: Extracorporeal membrane oxygenation for COVID-19. appeared first on Links Medicus.
France recommends single dose of vaccine if previous Covid infection detected.
France recommends single dose of vaccine if previous Covid infection detected – Rfi Related: [Preprint] More data showing a single-dose SARS-CoV-2 mRNA vaccine may be enough in individuals with previous COVID-19. AND Another study shows a single dose of mRNA vaccine may be enough for patients with previous Covid-19
The post France recommends single dose of vaccine if previous Covid infection detected. appeared first on Links Medicus.
A long-term perspective on immunity to COVID – “Clinical studies now indicate that immunity will be long-lasting”.
A long-term perspective on immunity to COVID – Nature
The post A long-term perspective on immunity to COVID – “Clinical studies now indicate that immunity will be long-lasting”. appeared first on Links Medicus.
M-A: The incubation period distribution of coronavirus disease 2019 – “the mean incubation period of COVID-19 was likely to fall between 5.2 and 7.2 days, and the 95th percentile would be between 11 and 14.6 days”.
The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis – Clinical Infectious Diseases
The post M-A: The incubation period distribution of coronavirus disease 2019 – “the mean incubation period of COVID-19 was likely to fall between 5.2 and 7.2 days, and the 95th percentile would be between 11 and 14.6 days”. appeared first on Links Medicus.
Cardio-pulmonary sequelae in recovered COVID-19 patients: considerations for primary care.
Cardio-Pulmonary Sequelae in Recovered COVID-19 Patients: Considerations for Primary Care – Journal of Primary Care & Community Health
The post Cardio-pulmonary sequelae in recovered COVID-19 patients: considerations for primary care. appeared first on Links Medicus.